InnovAge
INNV
#6548
Rank
โ‚น66.11 B
Marketcap
โ‚น487.25
Share price
4.85%
Change (1 day)
18.86%
Change (1 year)

Revenue for InnovAge (INNV)

Revenue in 2025 (TTM): โ‚น76.52 Billion

According to InnovAge's latest financial reports the company's current revenue (TTM ) is โ‚น79.82 Billion. In 2024 the company made a revenue of โ‚น69.19 Billion an increase over the revenue in the year 2023 that were of โ‚น60.00 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for InnovAge from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น76.52 B10.59%
2024 โ‚น69.19 B15.32%
2023 โ‚น60.00 B5.26%
2022 โ‚น57.00 B13.24%
2021 โ‚น50.34 B13.37%
2020 โ‚น44.40 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
AcelRx Pharmaceuticals
ACRX
โ‚น58.74 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
โ‚น328.84 B 311.95%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Cocrystal Pharma
COCP
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.796 T 7,160.96%๐Ÿ‡บ๐Ÿ‡ธ USA